Rephine extends its presence in India and Turkey

Published: 2-Feb-2021
Regulatory

Rephine announces the formation of subsidiaries and offices in both India and Turkey bringing its 23 years of experience in quality compliance and regulatory affairs to local customers

The Stevenage, UK-based company, already has an established presence in Germany, Poland, France, Spain and Italy, and has now announced the opening of two subsidiaries located in India and Turkey.

Rephine’s work in both India and Turkey has increased significantly and in addition to having a number of consultants and account managers based locally, now the company has established two legal entities and local offices.

All of Rephine’s services are available to local clients: compliance in GMP, Research Quality Assurance, and regulatory matters.

To read the full article, follow this link.

  • Companies:
  • Rephine
See more

You may also like

Regulatory

How to comply with regulatory expectations to access compliance data for the entire pharmaceutical supply chain

Read more
The pharmaceutical supply chain must work and must be known, is not a novel idea. Anyone involved in this industry’s quality processes knows that mastering 100% of its supply chain has been unachievable in the current state-of-the-art… until now!

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

How to comply with regulatory expectations to access compliance data for the entire pharmaceutical supply chain

The pharmaceutical supply chain must work and must be known, is not a novel idea. Anyone involved in this industry’s quality processes knows that mastering 100% of its supply chain has been unachievable in the current state-of-the-art… until now!
Regulatory

Five reasons why it is necessary to digitise supplier compliance information in pharma

Regulatory bodies have increased awareness about falsified drugs and subsequently worked out requirements to prevent falsified drugs entering the legal pharmaceutical supply chain.
Regulatory

Quality Risk Management explained

Rephine’s Roger Smith, Consultant and Auditor, explains in this new white paper
Regulatory

Rephine shares mantras for preparing a GMP audit in the COVID Era

Rephine’s Alessandro Manni, Consultant and Auditor, explains
Regulatory

White paper: Core Auditing Behaviours

Rephine's Roger Smith, Consultant and Auditor, explains
Regulatory

Understanding investigations, root causes and implementing an effective CAPA system

Rephine's white paper is available to download now
Training & Education

Rephine announces Symposium in February

The Symposium will specialise in GMP and Research QA
Subscribe now